Filtered by tag: addiction Remove Filter

Virtual Session Opioid and Diversion Awareness: The Current State of the Opioid Epidemic

Virtual Session Opioid and Diversion Awareness: The Current State of the Opioid Epidemic is closed but watch for new sessions in September

This virtual Event in July has sold out. However,  the same conference will be offered again on September 7 & 16, 2021. The sign up for the September event will be sent out in the coming weeks before September. Please check the DEA Diversion website for any additional conferences.

Any questions regarding this conference may be directed to DEA Liaison Section at [email protected].

Emergency Rule Related to Issuance of Prescriptions Renewed for 30 Days

Emergency Rule Related to Issuance of Prescriptions Renewed for 30 Days

The emergency rule related to the issuance of certain prescriptions during the COVID-19 disaster has been renewed for 30 days. 

The emergency rule (§174.5) continues to allow physicians to utilize telemedicine for issuing previous prescription(s) for scheduled medications to established chronic pain patients if the prescribing physician has, within the past 90 days, seen a patient in-person or via a telemedicine visit using two-way audio and video communication. 

The emergency rule will remain in place for 30 days (until July 30, 2021 at 11:59 p.m.) or for the duration of the time period that the Governor’s disaster declaration of March 13, 2020 in response to the COVID-19 pandemic is in effect, whichever is shorter, pursuant to Section 2001.034 of the Texas Government Code. 

Read More

We're back in person!

Meeting Registration is OPEN!

The Texas Pain Society’s Annual Scientific Meeting is the premier educational conference for pain management physicians in Texas. Each year over 200 physicians attend this one of a kind event.

Notable Pain Medicine-Specific CME Presentations will focus on the most current research and findings in pain medicine. Earn up to 17 AMA PRA Category 1tm and 2.75 hours of ethics/ professional responsibility in one weekend from distinguished state and national speakers.

1. Learn about the latest state law and rule changes from the Texas Medical Board and Texas State Board of Pharmacy and Drug Trafficking at the border

Read More

#TakeBackDay April 24, 2021

The DEA’s Take Back Day events provide an opportunity for Americans to prevent drug addiction and overdose deaths. Encourage the gathering of unused, unwanted, or expired prescription drugs to dispose of safely during the upcoming event.

When: Saturday,  April 24, 2021 – 10 AM to 2 PM

Read More

DEA Releases 2020 National Drug Threat Assessment


The 2020 NDTA is a valuable resource for all Americans, but especially those elected officials, law enforcement personnel, prevention and treatment specialists, and others who develop counter-drug policies, oversee law enforcement operations, and allocate resources.

 

The National Drug Threat Assessment (NDTA) is DEA’s annual comprehensive assessment of the threat posed to the United States by the trafficking and abuse of illicit drugs, the diversion and abuse of licit drugs, and the laundering of proceeds generated through illicit drug sales. 

 


Read More

3rd Annual Interdisciplinary Pain and Opioid Crisis Seminar on April 23-24, 2021

Dr. Eduardo Bruera, Chair of Palliative, Rehabilitation, and Integrative Medicine, and Dr. Joseph Arthur, (Conference Chair), Associate Professor in Palliative, Rehabilitation, and Integrative Medicine, invite you and your colleagues to join us for this outstanding educational opportunity. We are happy to announce that registration for the 3rd Annual Interdisciplinary Pain and Opioid Crisis Seminar on April 23-24, 2021, is now open.

The 3rd Annual Interdisciplinary Pain and Opioid Crisis Seminar is CME credited for those attending in real-time. Registration is now open and in line with our mission to present accurate data for a global audience.  We hope you will join us for this outstanding educational opportunity.

This will be a great opportunity for all APRNs who attend the conference to earn credit towards their regulatory controlled substance CE requirement.

- REGISTRATION IS NOW AVAILABLE -

Please share the information about this virtual education day with your colleagues.  We look forward to seeing you in April. 

 



Read More

BREAKING NEWS!

Breaking news!

Texas Pain Society is excited to release its very own Continuing Medical Education (CME) courses, courtesy of the Texas Pain Foundation. 

 As part of a TPS membership, CME hours are now available at little or no cost, compliments of Texas Pain Foundation. This is just one of the ways we are working to support our members.

Access our new CME Resource Page HERE

Interested in more free CME and benefits from TPS – consider joining today!

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain

Introduction

In an effort to address the opioid epidemic, a prominent goal of current research is to identify alternative treatments with equal or better benefits for pain while avoiding potential unintended consequences that could result in harms.

A systematic review assessing the effectiveness and harms of plant-based treatments for chronic pain conditions is underway. The review will be "living" in the sense that it will identify and synthesize recently published literature on an ongoing basis. For the purposes of this review, plant-based compounds (PBCs) included are those that are similar to opioids in effect and that have the potential for addiction, misuse, and serious adverse effects; other PBCs such as herbal treatments are not included. The intended audience includes policy and decision makers, funders and researchers of treatments for chronic pain, and clinicians who treat chronic pain.

The quarterly progress reports present the accumulating evidence and are updated on a regular basis. They include a description of the available studies and an appraisal of study quality. 

January 2021 Update

Overview

This is the first progress report for an ongoing living systematic review on plant-based treatments for chronic pain. The systematic review will synthesize evidence on the benefits and harms of plant-based compounds (PBCs) such as cannabinoids and kratom used to treat chronic pain, addressing concerns about severe adverse effects, abuse, misuse, dependence, and addiction.

Read More

#TakeBackDay this Saturday October 24th

The DEA’s Take Back Day events provide an opportunity for Americans to prevent drug addiction and overdose deaths. Encourage the gathering of unused, unwanted, or expired prescription drugs to dispose of safely during the upcoming event.

When: Saturday, October 24, 2020 – 10 AM to 2 PM

Read More

CDC & HHS Request for Comment Management of Acute and Chronic Pain

CDC & HHS Request for Comment Management of Acute and Chronic Pain

It is vitally important for the members of the Texas Pain Society to submit comments to CDC & HHS by June 16, 2020.

You can use the TPS template letter here

The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment concerning perspectives on and experiences with pain and pain management, including but not limited to the benefits and harms of opioid use, from patients with acute or chronic pain, patients' family members and/or caregivers, and health care providers who care for patients with pain or conditions that can complicate pain management (e.g., opioid use disorder or overdose)—hereafter called “stakeholders.” CDC will use these comments to inform its understanding of stakeholders' values and preferences related to pain and pain management options.
https://www.federalregister.gov/documents/2020/04/17/2020-08127/management-of-acute-and-chronic-pain-request-for-comment?deliveryName=Share%20Your%20Perspective%3A%20Management%20of%20Acute%20and%20Chronic%20Pain%20%28US&cid=em1003562&utm_source=sfmc_email&utm_medium=email-1st_party&utm_campaign=nmd-general-us-pain_medicine-general&utm_content=n-n-n-n&sid=0032K00002O0WULQA3&id_mc=552681762

Health Care Professionals and Facilities, Including Abortion Providers, Must Immediately Stop All Medically Unnecessary Surgeries and Procedures to Preserve Resources to Fight COVID-19 Pandemic

Texas Attorney General, Ken Paxton

FOR IMMEDIATE RELEASE

March 23, 2020

www.texasattorneygeneral.gov

Health Care Professionals and Facilities, Including Abortion Providers,

Read More

DEA Okays Telehealth to Prescribe Opioids Amid COVID-19 Emergency

The move to telehealth will make it easier for providers to prescribe an opioid or other controlled substance during the COVID-19 public health emergency.

telehealth prescribing of controlled substances

March 18, 2020 - Telemedicine has found yet another key purpose during the coronavirus public health emergency: the prescribing of controlled substances, such as opioids.

Per new clarification from the US Department of Justice Drug Enforcement Agency (DEA), healthcare professionals can now prescribe a controlled substance to a patient using telehealth technology.

This announcement comes in the wake of the public health emergency declared by HHS Secretary Alex Azar on January 31, 2020.

Read More

TMB Waiver for Chronic Pain Patients Granted by Governor Abbott

Texas Medical Board Press Release

 FOR IMMEDIATE RELEASE

March 19, 2020

Media contact: Jarrett Schneider, 512-305-7018

Read More

Addiction Medicine Fellowship Program

hrsa health workforce

Addiction Medicine Fellowship (AMF) Program

NOTICE OF FUNDING OPPORTUNITY (HRSA-20-013)
Fiscal Year 2020 Application Due Date: February 25, 2020

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year 2020 Addiction Medicine Fellowship (AMF) Program. The application cycle closes on February 25, 2020.

Please note that modifications have been made to the original Notice of Funding Opportunity. Download the latest version before applying.

Read More

DWC Finalizes the Medical Quality Review CY 2020 Annual Audit Plan

Division of Workers' Compensation banner

DWC Finalizes the Medical Quality Review CY 2020 Annual Audit Plan

On November 4, 2019, the Division of Workers’ Compensation solicited input for the 2020 Medical Quality Review Annual Audit Plan (Annual Plan); specifically, input regarding the proposal for categories within the Annual Plan.

The Annual Plan sets the priorities for the medical quality review audits during the upcoming year. This includes the scope, methodology, selection criteria, and program area responsibilities described in the Medical Quality Review Process .

More information about the Annual Plan is on the TDI website.

FindTreatment.gov is a pragmatic step in fight against opioids

The Trump administration has launched a smart new salvo in the public health offensive against the opioid epidemic.

Addiction to these prescription painkillers and related street drugs continues to wreak havoc in communities across the nation. Last week, the White House announced the launch of a new website that will make it easier to find specialized medical care close to home.

This confidential, easy-to-use resource has a name succinctly summing up its mission — FindTreatment.gov. It also allows individuals to customize their search results beyond location, a feature that existing “find a substance abuse provider” websites often don’t offer.

READ MORE

Attorney General Ken Paxton Issues Statement on Chapter 11 Bankruptcy Filing of Purdue Pharma

 

Attorney General Ken Paxton Issues Statement on Chapter 11

Bankruptcy Filing of Purdue Pharma

 

Read More

Prescription Drug Use Among Adults Aged 40–79 in the United States and Canada

This is the National Center for Health Statistics/CDC/HHS logo

Key findings

Data from the National Health and Nutrition Examination Survey and the Canadian Health Measures Survey

  • Nearly 7 in 10 adults aged 40–79 used at least 1 prescription drug in the past 30 days in the United States (69.0%) and Canada (65.5%), and around 1 in 5 used at least 5 prescription drugs (22.4% in the United States and 18.8% in Canada).
  • Among adults aged 40–59, the most commonly used drug types in the United States were antidepressants, lipid-lowering drugs, and ACE inhibitors; in Canada, they were analgesics, antidepressants, and lipid-lowering drugs.
  • Among adults aged 60–79, the most commonly used drug types in the United States were lipid-lowering drugs, antidiabetic agents, and beta blockers; in Canada, they were lipid-lowering drugs, analgesics, and proton pump inhibitors.

Patterns of prescription drug use may reflect underlying patterns of health conditions and health care access in the population. Polypharmacy, often defined as the simultaneous use of five or more prescription drugs, is more common in an aging population where multiple coexisting chronic conditions often occur; however, safety concerns may arise (1). The United States and Canada share many cultural and historical ties, but with different models for health care delivery (2). This report describes the use of one or more and five or more prescription drugs among adults aged 40–79 in the United States and Canada.

Read More

Keep enforcing marijuana laws, Abbott, Patrick, Bonnen, Paxton tell prosecutors amid hemp law confusion

Image result for dallas news logo

AUSTIN -- State GOP leaders have told local prosecutors not to abandon prosecution of marijuana-possession cases because of recently passed legislation legalizing hemp.

In a joint letter to district and county attorneys, Gov. Greg Abbott, Lt. Gov. Dan Patrick, Speaker Dennis Bonnen and Attorney General Ken Paxton emphasized Thursday that "marijuana has not been decriminalized in Texas." Prosecutors should not toss low-level marijuana cases, they said. In fact, the new hemp legislation gives law enforcement a new tool in pressing cases for marijuana possession, the leaders said.

READ MORE 

Governor Abbott Signs Opioid Legislation

Read More